Loading…

Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells

The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of pol...

Full description

Saved in:
Bibliographic Details
Published in:Doklady. Biological sciences 2016, Vol.466 (1), p.45-47
Main Authors: Kunts, T. A., Karpukhina, K. V., Mikhaylova, E. S., Marinkin, I. O., Varaksin, N. A., Autenshlyus, A. I., Lyakhovich, V. V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183
cites cdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183
container_end_page 47
container_issue 1
container_start_page 45
container_title Doklady. Biological sciences
container_volume 466
creator Kunts, T. A.
Karpukhina, K. V.
Mikhaylova, E. S.
Marinkin, I. O.
Varaksin, N. A.
Autenshlyus, A. I.
Lyakhovich, V. V.
description The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.
doi_str_mv 10.1134/S0012496616010026
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785243358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1785243358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</originalsourceid><addsrcrecordid>eNqNkUtLxDAUhYMoOj5-gBsJuHFTvUnaJF2KjA8QXKjrkqbJ0LGTjEkrzL83dUYRRXCVm3u-e3LJQeiYwDkhLL94BCA0LzknHAgA5VtokkqZMQLFNpqMcjbqe2g_xjmkOwi2i_aoAEqYgAmaT601usfe4qXvVrrzTnVY6b59U70PEXuH9ar3L60zeBl8MyQp9eoVrjvvG6xN10WsXDO2FqprZ065HtfBqNhjrZw2YQ0doh2rumiONucBer6ePl3dZvcPN3dXl_eZZhR4JnKqbc6oKTg1nDHJSitrUzaKNjJvCPuoZSmItIZaYQVhVhFgAE2SJTtAZ2vftO7rYGJfLdo4bqCc8UOsiJAFzRkr_oMKAaIo5Yie_kDnfgjpsz4oTktekDxRZE3p4GMMxlbL0C5UWFUEqjGz6ldmaeZk4zzUC9N8TXyGlAC6BmKS3MyEb0__6foOqLSfWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776296514</pqid></control><display><type>article</type><title>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</title><source>Springer Link</source><creator>Kunts, T. A. ; Karpukhina, K. V. ; Mikhaylova, E. S. ; Marinkin, I. O. ; Varaksin, N. A. ; Autenshlyus, A. I. ; Lyakhovich, V. V.</creator><creatorcontrib>Kunts, T. A. ; Karpukhina, K. V. ; Mikhaylova, E. S. ; Marinkin, I. O. ; Varaksin, N. A. ; Autenshlyus, A. I. ; Lyakhovich, V. V.</creatorcontrib><description>The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.</description><identifier>ISSN: 0012-4966</identifier><identifier>EISSN: 1608-3105</identifier><identifier>DOI: 10.1134/S0012496616010026</identifier><identifier>PMID: 27021370</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Biomedical and Life Sciences ; Blood Cells - metabolism ; Blood Cells - pathology ; Carcinogenesis - genetics ; Carcinoma, Ductal, Breast - blood ; Carcinoma, Ductal, Breast - genetics ; Carcinoma, Ductal, Breast - pathology ; Cell Biology ; Concanavalin A - pharmacology ; Enzyme-Linked Immunosorbent Assay ; Evolutionary Biology ; Female ; Granulocyte Colony-Stimulating Factor - blood ; Granulocyte Colony-Stimulating Factor - genetics ; Humans ; Interleukin-18 - blood ; Interleukin-18 - genetics ; Interleukin-6 - blood ; Interleukin-6 - genetics ; Life Sciences ; Lipopolysaccharides - pharmacology ; Mitosis - genetics ; Neoplasm Invasiveness - genetics ; Neoplasm Metastasis ; Neovascularization, Pathologic - genetics ; Neovascularization, Pathologic - pathology ; Phytohemagglutinins - pharmacology ; Plant Sciences</subject><ispartof>Doklady. Biological sciences, 2016, Vol.466 (1), p.45-47</ispartof><rights>Pleiades Publishing, Ltd. 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</citedby><cites>FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27021370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kunts, T. A.</creatorcontrib><creatorcontrib>Karpukhina, K. V.</creatorcontrib><creatorcontrib>Mikhaylova, E. S.</creatorcontrib><creatorcontrib>Marinkin, I. O.</creatorcontrib><creatorcontrib>Varaksin, N. A.</creatorcontrib><creatorcontrib>Autenshlyus, A. I.</creatorcontrib><creatorcontrib>Lyakhovich, V. V.</creatorcontrib><title>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</title><title>Doklady. Biological sciences</title><addtitle>Dokl Biol Sci</addtitle><addtitle>Dokl Biol Sci</addtitle><description>The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.</description><subject>Biomedical and Life Sciences</subject><subject>Blood Cells - metabolism</subject><subject>Blood Cells - pathology</subject><subject>Carcinogenesis - genetics</subject><subject>Carcinoma, Ductal, Breast - blood</subject><subject>Carcinoma, Ductal, Breast - genetics</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Cell Biology</subject><subject>Concanavalin A - pharmacology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Evolutionary Biology</subject><subject>Female</subject><subject>Granulocyte Colony-Stimulating Factor - blood</subject><subject>Granulocyte Colony-Stimulating Factor - genetics</subject><subject>Humans</subject><subject>Interleukin-18 - blood</subject><subject>Interleukin-18 - genetics</subject><subject>Interleukin-6 - blood</subject><subject>Interleukin-6 - genetics</subject><subject>Life Sciences</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Mitosis - genetics</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplasm Metastasis</subject><subject>Neovascularization, Pathologic - genetics</subject><subject>Neovascularization, Pathologic - pathology</subject><subject>Phytohemagglutinins - pharmacology</subject><subject>Plant Sciences</subject><issn>0012-4966</issn><issn>1608-3105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkUtLxDAUhYMoOj5-gBsJuHFTvUnaJF2KjA8QXKjrkqbJ0LGTjEkrzL83dUYRRXCVm3u-e3LJQeiYwDkhLL94BCA0LzknHAgA5VtokkqZMQLFNpqMcjbqe2g_xjmkOwi2i_aoAEqYgAmaT601usfe4qXvVrrzTnVY6b59U70PEXuH9ar3L60zeBl8MyQp9eoVrjvvG6xN10WsXDO2FqprZ065HtfBqNhjrZw2YQ0doh2rumiONucBer6ePl3dZvcPN3dXl_eZZhR4JnKqbc6oKTg1nDHJSitrUzaKNjJvCPuoZSmItIZaYQVhVhFgAE2SJTtAZ2vftO7rYGJfLdo4bqCc8UOsiJAFzRkr_oMKAaIo5Yie_kDnfgjpsz4oTktekDxRZE3p4GMMxlbL0C5UWFUEqjGz6ldmaeZk4zzUC9N8TXyGlAC6BmKS3MyEb0__6foOqLSfWw</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Kunts, T. A.</creator><creator>Karpukhina, K. V.</creator><creator>Mikhaylova, E. S.</creator><creator>Marinkin, I. O.</creator><creator>Varaksin, N. A.</creator><creator>Autenshlyus, A. I.</creator><creator>Lyakhovich, V. V.</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>2016</creationdate><title>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</title><author>Kunts, T. A. ; Karpukhina, K. V. ; Mikhaylova, E. S. ; Marinkin, I. O. ; Varaksin, N. A. ; Autenshlyus, A. I. ; Lyakhovich, V. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biomedical and Life Sciences</topic><topic>Blood Cells - metabolism</topic><topic>Blood Cells - pathology</topic><topic>Carcinogenesis - genetics</topic><topic>Carcinoma, Ductal, Breast - blood</topic><topic>Carcinoma, Ductal, Breast - genetics</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Cell Biology</topic><topic>Concanavalin A - pharmacology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Evolutionary Biology</topic><topic>Female</topic><topic>Granulocyte Colony-Stimulating Factor - blood</topic><topic>Granulocyte Colony-Stimulating Factor - genetics</topic><topic>Humans</topic><topic>Interleukin-18 - blood</topic><topic>Interleukin-18 - genetics</topic><topic>Interleukin-6 - blood</topic><topic>Interleukin-6 - genetics</topic><topic>Life Sciences</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Mitosis - genetics</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplasm Metastasis</topic><topic>Neovascularization, Pathologic - genetics</topic><topic>Neovascularization, Pathologic - pathology</topic><topic>Phytohemagglutinins - pharmacology</topic><topic>Plant Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kunts, T. A.</creatorcontrib><creatorcontrib>Karpukhina, K. V.</creatorcontrib><creatorcontrib>Mikhaylova, E. S.</creatorcontrib><creatorcontrib>Marinkin, I. O.</creatorcontrib><creatorcontrib>Varaksin, N. A.</creatorcontrib><creatorcontrib>Autenshlyus, A. I.</creatorcontrib><creatorcontrib>Lyakhovich, V. V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Doklady. Biological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kunts, T. A.</au><au>Karpukhina, K. V.</au><au>Mikhaylova, E. S.</au><au>Marinkin, I. O.</au><au>Varaksin, N. A.</au><au>Autenshlyus, A. I.</au><au>Lyakhovich, V. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</atitle><jtitle>Doklady. Biological sciences</jtitle><stitle>Dokl Biol Sci</stitle><addtitle>Dokl Biol Sci</addtitle><date>2016</date><risdate>2016</risdate><volume>466</volume><issue>1</issue><spage>45</spage><epage>47</epage><pages>45-47</pages><issn>0012-4966</issn><eissn>1608-3105</eissn><abstract>The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><pmid>27021370</pmid><doi>10.1134/S0012496616010026</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-4966
ispartof Doklady. Biological sciences, 2016, Vol.466 (1), p.45-47
issn 0012-4966
1608-3105
language eng
recordid cdi_proquest_miscellaneous_1785243358
source Springer Link
subjects Biomedical and Life Sciences
Blood Cells - metabolism
Blood Cells - pathology
Carcinogenesis - genetics
Carcinoma, Ductal, Breast - blood
Carcinoma, Ductal, Breast - genetics
Carcinoma, Ductal, Breast - pathology
Cell Biology
Concanavalin A - pharmacology
Enzyme-Linked Immunosorbent Assay
Evolutionary Biology
Female
Granulocyte Colony-Stimulating Factor - blood
Granulocyte Colony-Stimulating Factor - genetics
Humans
Interleukin-18 - blood
Interleukin-18 - genetics
Interleukin-6 - blood
Interleukin-6 - genetics
Life Sciences
Lipopolysaccharides - pharmacology
Mitosis - genetics
Neoplasm Invasiveness - genetics
Neoplasm Metastasis
Neovascularization, Pathologic - genetics
Neovascularization, Pathologic - pathology
Phytohemagglutinins - pharmacology
Plant Sciences
title Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A33%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20polyclonal%20activators%20on%20cytokine%20production%20by%20blood%20cells%20and%20by%20malignant%20breast%20cancer%20cells&rft.jtitle=Doklady.%20Biological%20sciences&rft.au=Kunts,%20T.%20A.&rft.date=2016&rft.volume=466&rft.issue=1&rft.spage=45&rft.epage=47&rft.pages=45-47&rft.issn=0012-4966&rft.eissn=1608-3105&rft_id=info:doi/10.1134/S0012496616010026&rft_dat=%3Cproquest_cross%3E1785243358%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1776296514&rft_id=info:pmid/27021370&rfr_iscdi=true